{"schema_version":"secwatch.filing_event.v1","accession":"0001688757-23-000073","form_type":"8-K","ticker":"ESTA","cik":"0001688757","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.860629+00:00","generated_at":"2026-06-12T02:17:05.692814+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Establishment Labs reports record Q2 revenue of $48.6M, up 18% YoY; net loss narrows to $16.7M","bullets":["Q2 2023 revenue of $48.6M (+18% YoY) sets new quarterly record; gross margin 62.3% vs 66.7% a year ago.","Net loss of $16.7M improved from $37.1M in Q2 2022; operating loss widened to $13.7M from $10.4M.","Cash balance $90.2M, boosted by April 27 follow-on offering of 1.265M shares.","FY 2023 revenue guidance maintained at $200-210M, representing 24-30% annual growth.","Mia Femtech has 14 clinic partners; U.S. PMA progressing; new Sulàyöm campus opened July 19."],"urls":{"canonical":"https://secwatch.observer/filing/0001688757-23-000073","json":"https://secwatch.observer/filing/0001688757-23-000073.json","markdown":"https://secwatch.observer/filing/0001688757-23-000073.md","text":"https://secwatch.observer/filing/0001688757-23-000073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000073/0001688757-23-000073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000073/esta-20230808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T02:17:05.692814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"359400bd62f9e87268fcdbbc5ba02e7761c2b2ae","claim":"ESTABLISHMENT LABS HOLDINGS INC. reported second quarter ended June 30, 2023 results: revenue $48.6 million, net income $16.7 million. Guidance reaffirmed.","evidence_excerpt":"and reconstruction, today announced financial results for the second quarter ended June 30, 2023. First Quarter Highlights and Outlook • Second quarter worldwide revenue of $48.6 million increased 18.0% year-over-year and was a new quarterly record. • 2023 revenue guidance remains $200 million to $210 million, an increase of 24% to 30% over 2022. • Second quarter","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000073/0001688757-23-000073-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$48.6 million"},{"label":"Net income","value":"$16.7 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e69ff4cc5c2f3c1d0f5a07254ac76499eb7f74b6","claim":"ESTABLISHMENT LABS HOLDINGS INC. reported financial results for six months ended June 30, 2023.","evidence_excerpt":"On August 8, 2023, Establishment Labs Holdings Inc. (the “Company”) issued a press release announcing the Company’s financial results for the three and six months ended June 30, 2023 and recent corporate highlights.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000073/0001688757-23-000073-index.htm","confidence":0.6,"family_label":"Earnings Releases","details":[{"label":"Period","value":"six months ended June 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}